Quick ReadPlain-language overview · read this first
Keysight Technologies is a platform company in high-end electronic test and measurement, selling hardware instruments, design simulation software, network and system validation, and calibration and repair services as a package to communications operators, aerospace and defense, automotive electronics, and semiconductor customers. Revenue was 5.375 billion U.S. dollars in fiscal 2025, with more than 40,000 customers worldwide and no single customer contributing more than 10% of revenue. Rating Watch -- the business quality, cash flow, and balance sheet all pass muster, but the current price has already prepaid for flawless execution over the next decade, leaving too little margin of safety for more conservative long-term capital.
The tension is not that the company is weak, but that the valuation embeds demanding assumptions. This is a high-quality business with a long-term gross margin above 60%, capital expenditure of only two to three points of revenue, cumulative free cash flow of 6.4 billion U.S. dollars over the past six years, a near net cash position, and diluted share count reduced through buybacks from 189 million shares to 173 million shares. In the first half of fiscal 2026, the Communications Solutions and Electronic Industrial Solutions segments grew 35% and 24% year on year, respectively, with the cycle moving upward. The problem is that a share price of 355.74 U.S. dollars implies a market capitalization of 61.5 billion U.S. dollars, about 45 times P/FCF, and nearly 53 times on a more conservative owner earnings basis. That is already mid-to-high pricing even among high-quality platforms, and the high growth in the first half of 2026 includes demand from AI and communications testing as well as the accounting effect of a one-time tariff refund, so it may not be fully extrapolatable.
On an owner earnings DCF basis, neutral intrinsic value falls in the 150-210 U.S. dollar range, with the optimistic case at 240-300 U.S. dollars. The current price is a premium to every range. The ideal buying range is 120-160 U.S. dollars, with a stronger preference below 150 U.S. dollars; above 300 U.S. dollars is clearly overvalued. The key risk to watch is not "the company getting worse," but a decline in the market's tolerance for 40-50 times cash flow multiples combined with worse-than-expected integration of Spirent and ESI. If the earnings center moves down while the valuation compresses, permanent capital loss of 50%-70% is not an exaggeration. For new capital, the more disciplined approach is to keep it near the top of the watchlist and wait for the price, rather than paying today for the future.
LeadKeysight Technologies is a high-end electronic test and measurement platform leader with fiscal 2025 revenue of $5.375 billion and a near net-cash balance sheet. The core thesis is that the business quality is strong, but the current $355 price implies about 45x P/FCF while my ideal buy range is $120-160. Report rating Watch: a high-quality compounder worth tracking, but current valuation leaves too little margin of safety.
Prices in the article are as of publication; see the valuation band above for the live price.
Bottom Line First
Investment rating: Watch.
Core judgment: From the perspective of a long-term business owner, Keysight Technologies is an understandable, high-quality test, measurement, and design-validation business with excellent cash-flow quality. It serves key technology sectors including communications, aerospace and defense, automotive, semiconductors, and general electronics. Its customer base is diversified, technical barriers are high, service and software revenue is rising as a share of the mix, and over the past several years the company has consistently converted free cash flow into buybacks, shrinking the share count. The issue is not "whether this is a good company," but "whether this is a good price today": as of the latest trading data, KEYS trades at about $355.74, with a market capitalization of about $61.5 billion and a trailing P/E of about 63.9x. Combining the company's free cash flow over the past 5-6 years, its current cash-flow yield, and my three-scenario owner-earnings DCF, I believe the current price does not leave enough margin of safety for a conservatively minded long-term investor.
Does the current price offer a margin of safety: No.
Suitable investor type: This is better suited to long-term quality-growth/value-hybrid investors who are willing to track high-quality technology infrastructure companies for years, provided they are also willing to wait for a more reasonable entry range. It is not suitable as a plain "low-valuation cigar-butt" value stock. Keysight looks more like a "high-quality business" than a "low-priced asset."
Largest uncertainties: First, fiscal 2026 first-half growth was extremely strong, but it mixed AI/data center demand, an upturn in communications testing, and one-time accounting effects related to tariff refunds. The boundary between "fundamental improvement" and "temporary tailwind" needs to be separated. Second, M&A has accelerated over the past two years. After the Spirent acquisition in particular, synergy realization and integration execution will be the most important proof points over the next three years. Third, the current valuation already asks a lot of the next decade's growth, margins, and valuation multiples. If any one of those disappoints, returns could be materially impaired.
My overall view upfront: This is a company worth studying and tracking for the long term, but not worth buying aggressively at the current price. For investors who already own it at a low cost basis, I lean toward "continue tracking and hold cautiously." For new capital, I lean toward "watch and wait for a better price." This is a classic case of a good company whose current price looks more like a bad price.
Facts, assumptions, inferences, and opinions: In this report, facts are drawn as much as possible from Keysight's latest 10-K, historical 10-Ks, fiscal 2026 Q1 and Q2 earnings materials, the 2026 proxy, the company's IR pages, and authoritative market data. Assumptions mainly appear in owner earnings, maintenance capital expenditure, discount rates, terminal growth rates, and exit multiples. Inferences mainly relate to moat breadth, reinvestment capacity, M&A synergy realization probability, and industry attractiveness. Opinions appear in the investment rating and buy-range conclusion.
Business Understanding
How does this company actually make money? At its core, Keysight sells hardware, software, and services across the full chain of design, simulation, validation, manufacturing test, and operations optimization to engineers and technology companies. In fiscal 2025, the company had two reporting segments: Communications Solutions Group and Electronic Industrial Solutions Group. The former serves commercial communications as well as aerospace, defense, and government customers; the latter serves automotive and energy, general electronics, semiconductors, and other electronic industrial customers. Fiscal 2025 total revenue was $5.375 billion, including product revenue of $4.063 billion and services and other revenue of $1.312 billion.
Who are the customers? Customers span the global communications ecosystem, aerospace and defense, automotive, energy, semiconductor, and general electronics markets. The company discloses that it does business with more than 40,000 customers each year, and that no single customer contributed more than 10% of revenue in 2025, 2024, or 2023. This matters: it means Keysight is not betting on one or two large accounts, but is rooted in a large and fragmented base layer of technology innovation infrastructure.
What does the company charge for? The revenue model is not one-dimensional. It sells one-time instrument hardware, perpetual and term software licenses, software subscriptions, SaaS, calibration, repair, extended warranties, technical support, training, and professional services. On revenue recognition, Keysight explicitly distinguishes between point-in-time recognition and over-time recognition: in fiscal 2025, about $4.337 billion was recognized at a point in time, and about $1.038 billion was recognized over time. Over-time revenue mainly came from repair and calibration contracts, extended warranties, technical support, software subscriptions, and certain professional services. In other words, this is not a pure "box-selling" hardware company; it is a test and measurement platform that is layering software/service stickiness onto hardware capability.
Is revenue recurring, stable, and predictable? My judgment is: above average, but not highly recurring in the SaaS sense. There are three layers of evidence. First, services and other revenue accounted for about 24.4% of fiscal 2025 revenue, clearly above about 18.7% in 2020. Second, deferred revenue at fiscal 2025 year-end was $884 million, up from $767 million in 2024, and the company disclosed that $513 million of 2025 revenue came from deferred revenue balances at the start of the year. Third, remaining performance obligations in fiscal 2025 were about $629 million, with 51% expected to be fulfilled in 2026. All of this shows that Keysight's revenue base is becoming more stable, while still retaining meaningful exposure to capex and R&D cycles.
What does the cost structure look like? This is not a heavy-asset manufacturer, but it is also far from "pure-software light." In fiscal 2025 costs and expenses, total cost of revenue was $2.038 billion, R&D was $1.007 billion, and SG&A was $1.474 billion. Capital expenditure was only $128 million, or about 2.4% of revenue. This shows that the company's core inputs are mainly R&D, sales, application support, and global service capability, not large-scale fixed-asset expansion. Its growth model is more "knowledge-capital intensive" than "plant-capital intensive."
Does it depend on a few customers, suppliers, channels, policies, or key people? Customers are not concentrated, but the supply chain is not free of fragility. The company discloses that materials come from thousands of suppliers globally, but some critical components that require custom design cannot be switched quickly to alternative suppliers. The company also clearly warns that tariffs, export controls, and U.S.-China trade friction affected results in fiscal 2025. In fiscal 2026 Q2, it also recognized receivable and liability items related to refunds after the IEEPA tariff judicial ruling. This means the business is diversified, but its supply-chain and policy exposures require ongoing monitoring.
Is the business simple, transparent, and easy to understand? It is understandable, but not simple. You can understand what it sells, who it sells to, and why customers are willing to pay. But truly judging its competitive advantages, product-generation shifts, and high-end testing demand requires continuous tracking of the technology roadmaps in communications, semiconductors, automotive electronics, and defense electronics. It belongs to the category of clear business logic with deep technical details.
If the stock market closed for 5 years, would I be willing to own this business? If the question is only about the "business," my answer is yes. If the question is whether I would buy it today at $355.74 and then have the market close for 5 years, my answer is not comfortably enough. The problem is not business quality; it is that the purchase price has already paid in advance for a lot of good news.
Business understandability score: 4/5.
Industry and Competitive Landscape
What stage is the industry in? Keysight is not in one single industry, but in the compound market of test, measurement, design validation, and network/system performance validation. On the demand side, it benefits from long-term technology upgrades in 5G/6G, AI data centers, next-generation semiconductors, vehicle electrification and intelligence, aerospace, and defense. At the 2023 Investor Day, management estimated its serviceable market at about $20.9 billion, with a long-term growth rate of about 4%-6%, and raised the long-term core growth target to 5%-7%. This means it is neither a declining industry nor an early-stage explosive-growth industry. It is closer to a mid-speed growth plus moderate-cycle industry driven by several long-term structural demand sources, while still disturbed in the short term by capex cycles. These TAM and share data are management estimates, not externally audited conclusions.
Is long-term industry demand stable? Over the long term, I believe it is stable and resilient. The reason is direct: electronic systems are becoming more complex, and chips, RF, optical, electrical, network protocols, power management, and security validation are all becoming harder. That raises the importance of testing and validation. But this is not a business with "essential demand and no cyclicality," because customer purchases often move with R&D budgets, carrier capex, semiconductor conditions, and defense order timing. In fiscal 2024, Keysight revenue declined to $4.979 billion, yet it still generated $833 million of operating profit, $1.052 billion of operating cash flow, and about $898 million of free cash flow. That shows the model can "slow down without bleeding" in a downturn.
Could the industry be disrupted by technology, regulation, or customer habits? Yes, but not in a "replaced overnight" way. Risks in test and measurement mainly come from three areas. First, technology migration, such as more workloads moving into software-defined simulation, cloud-based testing, and automated validation platforms. Second, policy disruption, including the impact of export controls, tariffs, and geopolitics on equipment, components, and customer demand. Third, changes in customer R&D cadence, especially in communications and semiconductor capex cycles. VIAVI's 2025 annual report also explicitly listed infrastructure upgrade timing, a highly concentrated customer base, pricing pressure from Asian competitors, and rapid technological change as key risks. Keysight's 2025 10-K similarly treated tariffs, export controls, and trade restrictions as material risks.
Who are the main competitors? Strictly speaking, Keysight does not have a public competitor that fully overlaps and maps one-to-one against it, because it spans RF/microwave measurement, network testing, electronic industrial testing, design software, and services. If we classify approximate comparables/partial competitors in the public market, I would divide them into three groups: First, in communications and network testing, VIAVI can be treated as a partial competitor/comparable; Second, in semiconductors and automated test equipment, Teradyne can be treated as a partial competitor/comparable; Third, in general industrial measurement/instrument platforms, Fortive and AMETEK can be used as references. I call these four companies a "public-market reference basket," not "perfect one-to-one competitors." In operating coverage, Keysight looks more like a compound platform spanning several test subsegments among these public companies. This definition is itself an inference based on business overlap.
What is the company's industry position? Using the company's own Investor Day framing, Keysight claims to be #1 in commercial communications, aerospace and defense, and electronic industrial markets, with a combined share of about 26%. Even without accepting that figure wholesale, the company is at least one of the world's highest-end electronic test and measurement platforms, as shown by its product matrix across design simulation, validation, network optimization, and the full software-and-services chain. In fiscal 2026 Q1 and Q2, both communications and electronic industrial segments delivered double-digit growth; in Q2, the communications segment grew 35% year over year, while the electronic industrial segment grew 24%. That indicates its competitive position remains strong in the current upcycle.
Is the industry profit pool concentrated, and does the company have pricing power? My inference is: the high-end profit pool is relatively concentrated, and Keysight has some pricing power, but it is limited. Evidence includes its sustained 60%+ gross margin, the rising services and software mix, proprietary core technology platforms and in-house IC fabrication capability, and customers' requirements for precision, compatibility, and response speed in high-end validation. On the other hand, this is not a consumer-staples business that can raise prices freely. Especially with large enterprise customers, government projects, and carriers, procurement tends to be rational, with price tied to function, precision, and schedule. In short, Keysight has technology-based pricing power, not monopoly pricing power.
Is this a good company in a good industry, or an excellent company in a bad industry? I lean toward the middle state within the former: it is not a perfect industry with naturally no cyclicality and naturally high recurring revenue, but it sits in an industry with decent long-term demand, high technical barriers, and clear customer value, and it is one of the better companies in that industry. My summary is: a high-quality platform company in a decent industry.
Industry attractiveness score: 4/5.
Moat and Management
Does a moat exist? My judgment is: yes, and it mainly comes from "technology platform + workflow embedding + service relationships," not from classic network effects.
Brand advantage: Yes. Keysight's electronic measurement business can trace its origins back to 1939. The company emphasizes that it works with 40,000+ customers globally and positions itself as a "trusted advisor and partner." In high-end test and measurement, brand is not a question of "awareness"; it is a question of "whether you dare entrust critical validation tasks to it." In that sense, the brand is real.
Cost advantage: Limited. It does not win by being the lowest-cost provider. It wins by measuring more accurately, measuring faster, integrating software and hardware more deeply, and offering stronger application support. It has some scale purchasing advantages and platform reuse advantages, but that is not its core moat. The real advantage lies in "total cost of ownership," not "lowest initial purchase price." This judgment is more of an inference, but it fits the company's high R&D spending and high gross-margin structure.
Scale advantage: Yes. In fiscal 2025, the company spent more than $1 billion on R&D. In fiscal 2026 Q1 alone, R&D spending was $303 million. That means replicating Keysight's coverage and refresh speed across multiple test subfields would require many years of continuous work and billions of dollars of R&D and sales-support investment. I infer that replicating a platform with similar credibility would typically require more than 5-10 years and enormous capital/talent investment.
Network effects: Weak. This is not a social platform or an exchange. More customers do not directly make the product "more useful" for each individual customer. Therefore, classic network effects are weak. Do not mistake a "broad ecosystem" for "strong network effects." I rate this item as weak.
Switching costs: Medium-high. Test platforms, automation scripts, instrument software, measurement methods, engineering processes, calibration systems, after-sales support, and employee familiarity create real migration friction once embedded in customer workflows. The company is also strengthening this stickiness through software subscriptions, technical support, KeysightCare, calibration contracts, extended warranties, and similar offerings. Compared with ERP or databases, its switching costs are not extremely high; compared with ordinary hardware, they are meaningfully higher.
Channel advantage: Yes. Keysight's core capability is not only selling equipment, but also global sales, application support, training, repair, calibration, license management, and delivery capability. For large technology customers, this global service network itself is part of the purchasing decision.
Patents, licenses, and regulatory barriers: Moderate. The company certainly owns many patents and intellectual-property rights, but it also acknowledges that in general, no single patent or intellectual-property right is by itself a "material single-point barrier," other than the Keysight trademark. This indicates that patents are more of an auxiliary moat than the main fortress. The main fortress remains integrated technical capability, workflow embedding, and customer trust.
Data advantage: Limited. This is not a platform company monetizing exclusive data. Its data advantage mainly lies in engineering application experience, testing methods, and understanding customer needs, not in an external-facing data network for sale. I rate this as weak to medium.
Corporate culture and operating capability: Relatively strong. The company discloses an average employee tenure of 12.4 years and a three-year average employee turnover rate of about 6.2%. This is not the entire moat, but in an industry highly dependent on measurement science, application engineering, and customer-support experience, low turnover and knowledge continuity matter. I view it as a "soft moat."
Capital allocation capability: Above average, but not outstanding. On the positive side, the company repurchased a large amount of stock from 2020 to 2025, reducing diluted shares from about 189 million to about 173 million in the first half of fiscal 2026. Recent repurchase average prices were roughly in the $140-170 range, which in hindsight is clearly below today's stock price. On the negative side, M&A accelerated meaningfully in 2024-2025. ESI Group and Spirent in particular brought large amounts of goodwill and intangible assets, and the value proof over the next three years is not yet complete. Therefore, I see capital allocation as rational and somewhat proactive, but not yet at a level that requires no doubt.
Is the moat widening, stable, or narrowing? My judgment is: overall stable, and marginally widening. The reason is that software, subscriptions, SaaS, services, and integrated simulation/testing are strengthening. In recent years, acquisitions such as ESI, Riscure, AnaPico, and Spirent have extended capabilities upstream and downstream. But I would not say the moat is "widening dramatically," because the industry itself faces technology iteration, customer-budget volatility, and geopolitical disruption.
Can the company raise prices in an inflationary environment? My conclusion is: it can raise prices partly, but not at will. High-end product differentiation and service contracts give it some ability to pass through costs. But tariff changes in 2025-2026 also show that price adjustments usually interact with customers, policy, and competition; they cannot be simplified into "costs rise, so everything is passed through without loss."
Can it remain profitable in an economic downturn? History suggests the answer is yes, very likely. Even under revenue pressure in fiscal 2024, the company still generated $833 million of operating profit, $1.052 billion of operating cash flow, and about $898 million of free cash flow. In fiscal 2020, during the pandemic environment, the company also generated $627 million of net income and $1.016 billion of operating cash flow. This is not "acyclical," but it is enough to show a business that can self-fund in downturns.
Were past high margins a structural advantage or a cyclical windfall? My judgment is: structural advantage forms the base, while cyclical tailwinds drive the swings. Gross margins above 60% and low capex intensity look more structural. The high growth and some profit elasticity in the first half of fiscal 2026 clearly include upcycle and one-time-item components.
Is management trustworthy and long-term oriented? The governance framework is generally sound. The 2026 proxy shows clear stock-ownership requirements for executives: the CEO must hold 6x annual salary, the CFO/COO must hold 3x annual salary or 80,000 shares, and other executives must hold 3x annual salary or 40,000 shares. As of fiscal 2025 year-end, all NEOs met the ownership requirements. The company has a clawback policy, prohibits hedging and pledging, restricts grant windows, and emphasizes that performance compensation is tied to revenue, EPS, operating margin, TSR, and other metrics. These lead me to a basically trustworthy assessment.
How aligned is management with shareholders? Alignment exists, but it is not the very strong founder-style alignment. According to the 2026 proxy, as of January 20, 2026, CEO Satish Dhanasekaran beneficially owned about 46,092 shares, and CFO Neil Dougherty owned about 93,508 shares. In absolute dollar terms this is not small, but as a share of total company equity it is still very low. Therefore, this is a "moderate-strength alignment achieved through compensation, ownership requirements, and governance mechanisms," not "management having a large share of their personal wealth at stake."
Management and capital allocation score: 3.5/5. I am willing to give an "above average" score, but I retain a discount for M&A integration uncertainty.
Financial Quality and Owner Earnings
Start with the financial big picture: One of the most important questions for long-term investing is whether the company earns "accounting profit" or "real cash profit." For Keysight, the answer leans toward the latter. From 2020 to 2025, cumulative net income was about $5.166 billion, cumulative operating cash flow was about $7.351 billion, and cumulative free cash flow was about $6.396 billion. In other words, cash flow not only matched net income, but was meaningfully higher than net income over the long term. This is a classic "good accounting earnings, even better cash earnings" company.
The table below is organized from the company's 2022, 2024, and 2025 10-Ks and fiscal 2026 Q2 earnings release. The primary basis is GAAP, and free cash flow = operating cash flow - purchases of property, plant and equipment. TTM is an approximate basis I calculated using fiscal 2025 and first-half fiscal 2026 data.
| Fiscal year/basis | Revenue ($bn) | Revenue growth | Gross margin | Operating margin | Net margin | Operating cash flow ($bn) | Capex ($bn) | Free cash flow ($bn) | FCF/net income | Diluted shares (mn) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2020 | 4.221 | Not shown | 60.0% | 18.1% | 14.9% | 1.016 | 0.117 | 0.899 | 1.43x | 189 |
| 2021 | 4.941 | 17.1% | 62.1% | 21.9% | 18.1% | 1.322 | 0.174 | 1.148 | 1.28x | 187 |
| 2022 | 5.420 | 9.7% | 63.7% | 24.6% | 20.7% | 1.144 | 0.185 | 0.959 | 0.85x | 182 |
| 2023 | 5.464 | 0.8% | 64.6% | 24.9% | 19.4% | 1.408 | 0.197 | 1.211 | 1.15x | 179 |
| 2024 | 4.979 | -8.9% | 62.9% | 16.7% | 12.3% | 1.052 | 0.154 | 0.898 | 1.46x | 175 |
| 2025 | 5.375 | 8.0% | 62.1% | 16.3% | 15.8% | 1.409 | 0.128 | 1.281 | 1.51x | 173 |
| TTM to 2026/4 | 6.088 | Approx. | 63.7% | 18.2% | 17.3% | 1.489 | 0.132 | 1.357 | 1.29x | 173 |
Financial interpretation: On revenue, Keysight shows the typical technology-infrastructure pattern of long-term upward movement with periodic drawdowns, not linear growth. On margins, 2022-2023 was the strongest phase in recent years, 2024 declined meaningfully, and 2025 recovered but had not yet returned to the peak. One important fact matters here: 2024 net income was disturbed by a one-time tax factor. In the 2025 10-K, the company explained that 2024 included deferred-tax effects related to Singapore tax-rate incentives, so the 2024 GAAP net margin should not be mechanically treated as permanent earning power.
Are profits real cash profits or accounting profits? My conclusion is: closer to real cash profits. Operating cash flow was significantly above net income in most years. Free cash flow exceeded net income in 5 of the 2020-2025 years, with only 2022 weaker due to working-capital and supply-chain factors. In the first half of fiscal 2026, operating cash flow was $942 million and free cash flow was $879 million, remaining strong.
Does growth require heavy capital investment? No. From 2020 to 2025, capex was roughly 2%-4% of revenue, which is not high for a high-end technology company with some in-house manufacturing and test platforms. The real growth investment mainly appears in R&D and M&A, not fixed assets. In other words, Keysight is a company with heavy expense-type reinvestment and light capex-type reinvestment.
Does the company make more money as it grows, or need more cash as it grows? Historically, it is closer to making more money and generating more cash as it grows. 2023 and 2025 are the clearest examples: when revenue was above $5 billion, the company still produced free cash flow at the billion-dollar-plus level. Even when conditions weakened in 2024, cash-flow resilience was strong. It is especially worth noting that services and other revenue grew from $789 million in 2020 to $1.312 billion in 2025. That revenue is usually more favorable than pure hardware for stabilizing cash flow and gross margin.
What about returns on capital? Based on my approximate calculation from public financial statements, Keysight's ROE in 2022-2025 was about 12.6%-28.3%, and about 15.5% in 2025. ROA was about 6.8%-14.2%, and about 8.3% in 2025. Approximate ROIC was very attractive in 2022-2023, then fell back to around 12%-13% in 2024-2025. For a high-end test platform with accelerating M&A but very strong cash flow, that is still a decent level, just not "extremely excellent today." This ROIC is an approximate analytical calculation based on GAAP operating profit, effective tax rate, and net operating invested capital, and should be viewed as an analytical estimate rather than an official company disclosure.
Is the balance sheet sound? Yes, overall. At 2025 year-end, the company had $1.873 billion of cash, $211 million of long-term investments, and $2.534 billion of total debt. By April 30, 2026, cash and restricted cash totaled about $2.430 billion, and total debt was about $2.531 billion, putting the company close to net-cash/net-debt balance. Net debt/EBITDA at 2025 year-end was roughly within 0.6x, and by the end of April 2026 it was close to zero net debt. 2025 EBIT/interest expense was about 9x, and TTM was about 10x. In addition, the company's credit ratings from Fitch, Moody's, and S&P were BBB+ / Baa1 / BBB, which indicates investment-grade debt risk.
Has working capital deteriorated? As of the end of April 2026, accounts receivable were $1.022 billion, inventory was $1.038 billion, and accounts payable were $392 million, all broadly controlled. In fiscal 2025, the company disclosed that AR, inventory, and AP combined provided $25 million of cash. In the first half of fiscal 2026, receivables increased, inventory declined slightly, and deferred revenue increased, reflecting normal working-capital pull from an upturn rather than obvious loss of control.
Accounting risk, aggressive accounting, or signs of fraud? I do not see obvious signs of fraud, for three reasons. First, long-term cash flow is significantly stronger than net income. Second, PwC has served as the company's auditor since 2013. Third, the real caution is not "fabricated revenue," but that post-M&A goodwill/intangible amortization, non-GAAP adjustments, and one-time items can mislead investors about "true earnings." Recent acquisitions have lifted goodwill and intangible assets meaningfully. If integration disappoints in the future, impairment risk will rise.
Owner Earnings analysis. Using a more conservative "owner earnings" basis, I do not treat stock-based compensation directly as "cost-free earnings." I start from TTM free cash flow of about $1.357 billion, then deduct the economic dilution to shareholders from TTM stock-based compensation. Based on public data, TTM stock-based compensation is approximately $198 million. Therefore, a more conservative Owner Earnings figure is about $1.15-1.20 billion; I use the midpoint of $1.16 billion. That corresponds to about $6.7/share of owner earnings, or about 53x Owner Earnings at the current share price. If you do not use the most conservative treatment of "SBC as a real cost" and instead use free cash flow directly, the current valuation is still about 45x FCF. Either way, it is hard to call cheap. This Owner Earnings figure is an analytical estimate, not an official company metric.
Intrinsic Value, Valuation, and Margin of Safety
As of the latest trading data, KEYS trades at about $355.74, implying a market capitalization of about $61.5 billion. Using my TTM calculation based on fiscal 2025 and first-half fiscal 2026 data, Keysight currently trades at roughly about 45x P/FCF, about 9.7x P/B, and about 42x EV/EBITDA. Using the more conservative Owner Earnings basis, the price is about 53x. This means the market is already pricing it as a "high-quality, sustainably growing asset that can maintain a high valuation for many years."
Method 1: Owner-earnings discounted cash flow. My base starting point is conservative Owner Earnings of $1.16 billion, assuming net cash is approximately zero. The core reason is that I am unwilling to treat long-term stock-based compensation entirely as a "non-cash, negligible item." A DCF essentially asks one question: if I bought the entire company today, how much cash could truly be distributed to me over the long run? On this point, Keysight's cash generation is good, but the current price asks too much.
| Scenario | Initial Owner Earnings | First 10-year growth assumption | Discount rate | Terminal growth rate | Estimated intrinsic value per share |
|---|---|---|---|---|---|
| Conservative | $1.16 billion | 4% | 10% | 3.0% | About $107 |
| Base | $1.16 billion | 7% | 9% | 3.0% | About $156 |
| Bull | $1.16 billion | 10% | 8% | 3.5% | About $259 |
These values are the strictly conservative version. If you use FCF without deducting stock-based compensation, valuation rises by a step. If you believe Spirent synergies, continued software/service mix expansion, and long-term non-GAAP operating-margin targets can be realized, the upper end can rise further. Even so, I still find it hard to push today's reasonable intrinsic value above $355. Based on a synthesis of different methods, my range is: conservative intrinsic value $110-140; reasonable intrinsic value $150-210; optimistic intrinsic value $240-300. These valuation ranges are analytical inferences based on public financial data and explicit assumptions.
Method 2: Relative valuation. Relative valuation can easily lead investors into a trap, because "peers are all expensive" does not mean "this one is cheap." In the public market, Teradyne currently trades at a PE of about 72.2x, AMETEK at about 34.7x, Fortive at about 36.1x, while VIAVI is still near low-profit/loss territory on GAAP earnings, making PE distorted. Keysight's current PE is about 63.9x. On static PE, its valuation is below Teradyne's but meaningfully above AMETEK's and Fortive's. The issue is that Teradyne is more visibly benefiting from AI-driven semiconductor-test demand, while AMETEK and Fortive have different business stability and portfolio structures from Keysight. Therefore, looking only at peer multiples, KEYS cannot be called cheap; it is better described as mid-to-high within a high-quality, high-valuation group.
Method 3: Asset/liquidation value. Looking at Keysight through an asset-value lens gives a harsh conclusion: it is not an asset-backed stock. As of April 30, 2026, shareholders' equity was about $6.331 billion. Goodwill was $3.465 billion and net intangible assets were $1.174 billion. That leaves tangible net assets of only about $1.69 billion, or less than $10/share. This does not mean the company is worth only that much. It means its value comes almost entirely from going-concern earning power, not liquidation residual value. For long-term buyers, that is normal; for conservative investors focused on margin of safety, it means valuation judgment must be more cautious than simply reading the balance sheet.
Discount or premium of the current price to intrinsic value. If I use my "reasonable intrinsic value range" of $150-210, the current price of $355.74 represents roughly a 69%-137% premium. Even compared with the "optimistic intrinsic value range" of $240-300, the current price is roughly 19%-48% higher. This means buying today depends heavily on the company executing extremely well for the next decade, sustaining growth above the industry, and the market remaining willing to assign a high valuation. That outcome is possible, but for balanced and conservative capital, it is not comfortable enough.
Ideal buy range, acceptable hold range, and clearly overvalued range. My conclusion is clear: For the ideal buy range, I would write $120-160, with below $150 closer to a "seriously consider with margin of safety" zone; If you already own it long term and face high taxes or redeployment costs, then $160-240 can still be viewed as an "acceptable hold price range"; Above $300, in my framework, enters the "clearly overvalued" zone. This is a conservative value-investing framework conclusion, not a short-term price target.
Margin of safety judgment. None. The most fragile assumption here is not one or two years of revenue growth, but whether the market will always be willing to pay 40-50x cash flow for Keysight's quality attributes. If future growth falls short, margins recover less than expected, or valuation multiples fall from elevated levels back toward normal quality-stock ranges, investment returns could be easily consumed. For conservative investors, I do not think the odds are currently good enough.
Risks, Comparisons, Checklist, and Final Conclusion
Most important risks. I think six categories need close attention. First, competitive risk: the high-end test and measurement market appears to have high barriers, but if platform migration, software-based substitution, or key-customer preference shifts occur in a subsegment, share changes can accumulate slowly. Second, technology substitution risk: rising shares of design simulation, automation, and cloud-based testing will affect how traditional high-end instruments capture value. Third, regulatory and geopolitical risk: tariffs, export controls, U.S.-China relations, and localization requirements have already left visible traces in 2025-2026 financial statements. Fourth, M&A integration risk: ESI Group and Spirent expanded the capability boundary, but also raised goodwill and intangible assets. Fifth, cycle risk: communications, semiconductors, and automotive electronics all carry capex cycles. Sixth, overvaluation risk: this is the most practical risk today, because even if the company remains excellent, returns may be eaten by the entry valuation.
Strongest bear case. If I were bearish, I would say: Keysight is indeed a good company, but the market has already priced it for a script of "sustained high growth for the next decade, margin recovery, successful M&A, and no valuation derating." The high growth in the first half of fiscal 2026 may include temporary pulls from AI/data centers and communications test demand, while Q2 also included tariff-refund-related accounting items. When conditions normalize, the market may no longer accept a free-cash-flow multiple above 45x. In short, the risk may not be "the company gets worse," but "the price paid is too expensive."
What facts would overturn the investment judgment? If the following facts appear in the future, I would admit the original judgment on business quality was wrong: First, software, services, and support growth stalls, and deferred revenue plus over-time revenue share no longer rise; Second, Spirent and ESI synergies fail to materialize, causing goodwill impairment or ROIC to remain near the cost of capital for a long time; Third, the company posts high growth for several consecutive years but free cash flow fails to keep up, or cash flow is materially below net income; Fourth, core share in communications and electronic industrial markets keeps being ceded, while the company cannot offset that with higher-value software and system solutions; Fifth, the balance sheet moves from near net cash toward high leverage. These would materially change the long-term business-owner framework.
Largest permanent capital-loss scenario. The worst-case scenario is not a quarterly miss. It is: M&A integration goes poorly, the cyclical peak rolls over, margins recover less than expected, and the market compresses the valuation from 40-50x cash flow back to 20-25x. In that scenario, a 40%-60% or even larger long-term drawdown would not be unimaginable. If the earnings base also declines, permanent loss could be greater. Its liquidation value provides very limited protection for shareholders.
Comparison with other opportunities. Compared with diversified exposure to the S&P 500, I do not think KEYS currently offers clearly better odds. Compared with the risk-free rate, the issue is sharper: the U.S. Treasury 10-year constant maturity rate on May 26, 2026 was about 4.50%, while KEYS' TTM free-cash-flow yield by my calculation was only about 2.2%, and below 2% on the conservative Owner Earnings basis. This means buying KEYS today is effectively an active decision to give up a currently higher risk-free yield and instead bet on many years of growth and valuation persistence. For conservative investors, that exchange is not attractive.
If I could hold only 5 assets, would it qualify for the portfolio? At the current price, my answer is: no. Not because the company is not good enough, but because relative to other opportunities, its return/risk ratio is not outstanding enough. If the price returned to my ideal buy range, that conclusion would change.
Investment Checklist.
| Checklist item | Conclusion |
|---|---|
| Can I understand this business? | Pass |
| Does it have stable long-term demand? | Pass |
| Does it have a durable moat? | Pass |
| Does it have pricing power? | Uncertain |
| Can it generate stable free cash flow? | Pass |
| Are returns on capital excellent? | Pass |
| Is management trustworthy? | Pass |
| Is capital allocation rational? | Uncertain |
| Is the balance sheet sound? | Pass |
| Is valuation below intrinsic value? | Fail |
| Is the margin of safety sufficient? | Fail |
| Would I feel comfortable holding it long term? | Uncertain |
| What key facts would make me sell? | See trigger signals below |
| Am I only tempted to buy because the share price has risen or market sentiment is strong? | Currently easier to misjudge as "yes" |
The core meaning of this checklist is simple: the business judgment mostly passes; the price judgment clearly does not.
Final investment conclusion.
【Final Rating】 Watch
【One-sentence investment thesis】 Keysight is a high-quality test and measurement platform with excellent cash flow and a moat built on technology and workflow embedding, but buying at the current price makes future returns depend more on optimistic assumptions than on a margin of safety.
【Core bullish reasons】
The business is rooted in long-term technology-upgrade spending across communications, semiconductors, automotive, defense, and other sectors, with healthy underlying demand logic.
Customers are diversified, technology depth is high, and software and services are rising as a share of revenue, strengthening resilience.
Cash-flow quality is high, long-term FCF is meaningfully stronger than net income, and capex intensity is low.
The balance sheet is solid, close to net cash, with investment-grade credit ratings.
The governance framework is generally disciplined, and the share count has consistently declined over the past several years.
【Core bearish reasons】
The current valuation is too high; P/FCF, EV/EBITDA, and Owner Earnings multiples are all not cheap.
The high growth in the first half of fiscal 2026 may not be fully sustainable, and Q2 included one-time accounting effects related to tariff refunds.
M&A has significantly increased goodwill and intangible assets; integration failure would hurt returns and asset quality.
The business is still affected by communications/semiconductor/automotive capex cycles and geopolitical/regulatory disruption.
【Key assumptions】
The company can still sustain mid-to-high single-digit or better core growth over the next 5-10 years.
Software, services, and support revenue continue to improve revenue resilience and earnings quality.
Spirent, ESI, and other acquisitions deliver synergies rather than impairments.
The market does not sharply compress the valuation multiple back toward the range of ordinary industrial-equipment companies. These are assumptions required for the investment to work, not facts that have already happened.
【Fair Buy Price】 My fair buy range is $120-160, with a stronger preference for below $150. This is based on conservative Owner Earnings DCF, FCF DCF, and the discount required versus today's high-valuation peer group. This range is not "a prediction that the stock will fall here"; it is "the odds at which I would be more willing to become a long-term business owner."
【Target holding period】 If bought at a reasonable price, I think it is suitable for holding for more than 10 years. If bought at the current price, I think even a long holding period may not be enough to compensate for single-stock risk.
【Expected annualized return】 Starting from the current price, my rough judgment is:
Conservative scenario: -3% to 0%/year.
Base scenario: 2% to 4%/year.
Bull scenario: 6% to 8%/year. These return ranges embed different combinations of growth, margin recovery, and exit valuation over the next 10 years. They are valuation-model inferences, not statements of fact. They are low because today's purchase price is already high.
【Maximum loss risk】 In a pessimistic but not absurd scenario, if the earnings base declines and the market rerates the company to 20-25x conservative Owner Earnings, a 50%-70% medium-to-long-term share-price decline is not impossible. The cause would probably not be "the company immediately breaks," but the combined effect of "high valuation + slower growth + weaker-than-expected integration."
【Tracking metrics】 Going forward, I would keep tracking:
Organic growth in CSG and EISG.
Services and other revenue share, and over-time revenue share.
Matching between operating cash flow, free cash flow, and net income.
Whether ROIC returns to and stabilizes in the mid-teens.
Spirent synergy realization progress and changes in goodwill/intangible assets.
Gross-margin and operating-margin recovery.
Deferred revenue, remaining performance obligations, and order cadence.
The impact of geopolitics, tariffs, and export controls on revenue and costs.
【Signals that would trigger reassessment】
Several consecutive quarters of "revenue growth, but free cash flow clearly not keeping up."
Goodwill impairment after the Spirent or ESI acquisitions, or delayed/canceled synergy targets.
Services/software mix stops rising, and deferred revenue plus over-time revenue weaken.
High-end test platforms lose share in key markets.
Leverage rises meaningfully, pressuring investment-grade credit.
Valuation rises further away from the cash-flow foundation. If these signals appear, investors should reassess whether this is still the same business they were willing to own for the long term.
【Final recommendation】 I would place Keysight near the top of a high-quality watchlist, but I would not treat it as a value investment with margin of safety at the current price. For conservatively minded long-term capital, the most disciplined and rational action is not to chase the stock, but to recognize that a good company does not automatically equal a good investment; price determines return. If the market offers a more reasonable entry window in the future, it will be highly worth revisiting. Today, however, I would rather remain patient than prepay for a decade of perfect execution.
Open Questions and Limitations
Three points need to be stated clearly. First, as of this research date, the full fiscal 2026 Q2 10-Q was not incorporated into this report; some latest-quarter data come from the company's May 19, 2026 earnings press release and schedules, so the analysis of the latest quarter is not as deep as a 10-K-based review. Second, peer comparison for Keysight naturally has an "imperfect comparability" problem, because the company spans multiple test and validation submarkets. Therefore, I ran more detailed calculations on KEYS itself and emphasized qualitative comparison rather than mechanical table matching for peers. Third, the TAM, share, and long-term growth data from Keysight Investor Day are management estimates. I treat them as reference points, not unquestionable facts.
This report is based on public information and does not constitute investment advice. Markets carry risk; invest with caution.
Full report
Sign in to read the full report
Sign up free to unlock the full text, the Baillie growth scorecard, and full-text search.
Log in / Sign up free